Abstract 298P
Background
It was still controversial regarding the postoperative preservation of pulmonary function after segmentectomy over lobectomy. In particular, resection for three or more segment was associated with more profound decreased in lung function. The purpose of this study was to investigate the effect of left upper division (LUD) segmentectomy on postoperative pulmonary function and lung volume comparison of left upper lobectomy among clinical stage IA non-small cell lung cancer (NSCLC).
Methods
Among clinical stage IA NSCLC patients who underwent LUD segmentectomy or left upper lobectomy between 2013 and 2018, postoperative changes in pulmonary function, 3-dimensional computed tomography (CT) volumetry and the percentage of low attenuation areas (% LAAs) were retrospectively reviewed according to surgical procedure. Changes in pulmonary function by groups were compared using linear mixed model with linear spline, random intercepts and slope.
Results
A total of 264 patient were identified, the study group consisted with 85 LUD segmentectomy (32.2%) and 179 left lobectomy (67.8%). In the adjusted model, no significant difference was observed among changes in pulmonary function by surgical procedure. In terms of lung volume, postoperative volume in contralateral lung and LLL was increased in both groups, it is more likely to have greater increase in LLL volume in lobectomy group (333.4 vs. 451.6 ml, p<0.001) than those in segmentectomy group. After surgery, the % LAA of left lung and LLL in the lobectomy group significantly increased compared to those in the segmentectomy group (0.37 vs. 1.31, p=0.002; 0.53 vs. 1.82, p<0.001), while change of % LAA of right lung was not significantly differ by surgical procedure. In the linear regression model, changes in lung volume and % LAA in left lung and LLL was significantly associated with type of surgery.
Conclusions
Postoperative changes in pulmonary function after LUD segmentectomy and left upper lobectomy was not significantly different. However, segmentectomy was significantly associated with less volume expansion and less increased % LAA compared with those in lobectomy.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
281P - Cancer-related symptoms as mediators between treatment and functional capacity in adolescents and young adults (AYAs) with cancer
Presenter: Chung Tin Justin Ma
Session: Poster viewing 04
282P - Nutritional status and nutritional therapy of common cancer in a cancer hospital of Southwest China
Presenter: Huiqing Yu
Session: Poster viewing 04
283P - Comparative analysis of osteoporotic fracture (OF) and pathologic fracture (PF) in patients with metastatic colorectal cancer (mCRC) who received palliative chemotherapy
Presenter: Yejee Lim
Session: Poster viewing 04
284P - Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet
Presenter: Haoyang Cao
Session: Poster viewing 04
285P - Reticulocyte hemoglobin equivalent as an early predictor of iron deficiency anemia in cancer patients
Presenter: Aditya Sarin
Session: Poster viewing 04
286P - Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
Presenter: Amy Body
Session: Poster viewing 04
287P - Long-term yoga enhances the quality of life and symptomatic scale in breast cancer patients undergoing treatment
Presenter: Mayank Jain
Session: Poster viewing 04
288P - Impact of hormonal contraception on estradiol and progesterone serum levels: A 6-year study on progression-free survival, disease-free survival, and overall survival at Dr. Moewardi Hospital
Presenter: Widyanti Soewoto
Session: Poster viewing 04
289P - Cancer cachexia following breast cancer (BC) chemotherapy was associated with clinical stage, number of chemotherapy cycles, and vitamin D concentration
Presenter: Susanna Hutajulu
Session: Poster viewing 04
290P - Use of PEG G-CSF is associated with decreased myelotoxicity in dexrazoxane-used aggressive non-Hodgkin lymphoma patients
Presenter: Sung-Nam Lim
Session: Poster viewing 04